New study offers hope for a rare and devastating eye cancer
Researchers have found a treatment that works on some patients and, more importantly, a tool that can predict when it is likely to succeed.
Source: washingtonpost.com
Ryanj Sullivan News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ryanj Sullivan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ryanj Sullivan Today - Breaking & Trending Today
Study Reinforces BRAF-MEK Inhibition Over Anti-BRAF Only in Advanced Melanoma
Improved PFS with encorafenib-binimetinib versus encorafenib, but immunotherapy still top option
Source: medpagetoday.com
Dr Sullivan on the Reduction of ctDNA With Tebentafusp in Metastatic Uveal Melanoma
Ryan J. Sullivan, MD, discusses the early reduction of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp and shares how these reductions could correlate with longer overall survival in patients with a best response of stable disease.
Source: onclive.com
Early ctDNA Testing Provides Another Tool for Predicting Survival Outcomes With Tebentafusp in Metastatic Uveal Melanoma
Ryan J. Sullivan, MD, discusses previous research on tebentafusp in uveal melanoma that led to the inception of the IMCgp100-202 trial and clinical implications for data confirming the predictive value of circulating tumor DNA levels.
Source: onclive.com
Dr Sullivan on Pseudoprogression as a Potential Explanation for Outcomes With Tebentafusp in Uveal Melanoma
Ryan J. Sullivan, MD, explains the prolongation of survival with tebentafusp-tebn despite apparent initial radiographic tumor progression in patients with uveal melanoma.
Source: onclive.com